Le Lézard
Classified in: Health
Subjects: NPT, PER

Association for the Advancement of Wound Care Announces Chief Executive Officer


MALVERN, Pa., Oct. 10, 2017 /PRNewswire-USNewswire/ -- The Association for the Advancement of Wound Care (AAWC) announces Victoria E. Elliott, RPh, MBA, CAE, as the new Chief Executive Officer. Ms. Elliott brings a wealth of experience in association management. As a Certified Association Executive (CAE), her qualifications include alliance building, membership growth, volunteer engagement and leadership development. Ms. Elliott has served as Executive Director for the American Neurological Association, Dermatology Nurses' Association, Attention Deficit Disorder Association, Society For Biomaterials and the Pennsylvania Society of Health System Pharmacists. Most recently she was Director of Development at the University of the Sciences where she focused on individual alumni giving, and student and parent fundraising campaigns.

Victoria E. Elliott, RPh, MBA, CAE, Chief Executive Officer, Association for the Advancement of Wound Care

Ms. Elliott stated that she is "excited to join the AAWC management team, and looks forward to working with the association's leadership to broaden knowledge of effective treatment options for wound management, seek appropriate federal support for wound healing professionals, and advance the importance of an interdisciplinary approach to patient wound healing and tissue preservation."

Ms. Elliott earned her BS in Pharmacy at the Philadelphia College of Pharmacy, now part of the University of the Sciences, and an MBA in Health and Medical Services Administration at Widener University. Her pharmacy career was spent largely in hospital practice where she specialized in pediatrics and hospital pharmacy administration. Ms. Elliott is a member of the American Society of Association Executives, the organization that confers the certification in association management (CAE), and a past president of the Mid-Atlantic Society of Association Executives where she remains an active member.

ABOUT AAWC - AAWC is the leading, nonprofit membership organization in the US dedicated to interprofessional wound healing and tissue preservation. The Association's focus is on education, public policy, and the application of evidence-based wound care practice. AAWC membership is open to anyone involved in wound care, including clinicians, nurses and other allied healthcare professionals, patients, caregivers, clinics/facilities and corporations. There are numerous ways that one can make a difference at AAWC. Considering joining as a professional or discover our patient/caregiver advocacy network and join for free.

AAWC is the leading, nonprofit organization in the United States dedicated to interdisciplinary wound healing and tissue preservation. With a mission to advance the care of people with and at risk for wounds, AAWC offers membership to everyone involved in wound care - clinicians, researchers, educators and other healthcare professionals; patients and lay-caregivers; clinics, hospitals and other healthcare facilities; corporations and manufacturers; students and retirees; and advocates. (PRNewsFoto/AAWC)

SOURCE Association for the Advancement of Wound Care


These press releases may also interest you

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas Pharma Inc....

at 19:15
Denver nonprofit Justice Necessary unveils data from its latest study on teen period poverty in Colorado, shedding light on a deeply concerning issue. The findings of this study underscore the urgent need for action to address the need for teens to...

at 19:05
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...

at 18:00
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:45
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th ? May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent,...



News published on and distributed by: